2 unchanged sentences
We only have one class of common stock.
−Removed: Our common stock is listed on the New York Stock Exchange under the symbol “PKI”.
−Removed: As of February 24, 2023, we had approximately 3,056 holders of record of our common stock.
+Added: Our common stock is listed on the New York Stock Exchange under the symbol “RVTY”.
+Added: As of February 23, 2024, we h ad approximately 2,923 holders of reco rd of our common stock.
Stock Repurchases
14 unchanged sentences
57 87.85 — 355,447,934
−Removed: November 28, 2022 - January 1, 2023
+Added: November 27, 2023 - December 31, 2023
125 101.31 — 355,447,934
−Removed: Activity for quarter ended January 1, 2023 182,619 $ 134.16 138,025 $ 280,862,780
+Added: Activity for quarter ended December 31, 2023
45,905 $ 107.59 — $ 355,447,934
+Added: ________________
(1) Our Board of Directors (our “Board”) has authorized us to repurchase shares of common stock to satisfy minimum statutory tax withholding obligations in connection with the vesting of restricted stock awards and restricted stock unit awards granted pursuant to our equity incentive plans and to satisfy obligations related to the exercise of stock options made pursuant to our equity incentive plans.
2 unchanged sentences
(2) On July 22, 2022, our Board authorized us to repurchase shares of common stock for an aggregate amount up to $300.0 million under a stock repurchase program (the “Repurchase Program”).
−Removed: On July 22, 2022, the Repurchase Program was terminated by our Board and our Board authorized us to repurchase shares of common stock for an aggregate amount up to $300.0 million under a new stock repurchase program (the “ New Repurchase Program ” ).
+Added: On April 27, 2023, the Repurchase Program was terminated by our Board and our Board authorized us to repurchase shares of common stock for an aggregate amount up to $600.0 million under a new stock repurchase program (the “New Repurchase Program”).
+Added: The New Repurchase Program will expire on April 26, 2025, unless terminated earlier by our Board and may be suspended or discontinued at any time.
+Added: During fiscal year 2023 , we repurchased 1,004,544 shares of common stock under the Repurchase Program for an aggregate cost of $131.3 million.
No shares remain available for repurchase under the Repurchase Program due to its termination.
−Removed: The New Repurchase Pro gram will expire on July 22, 2024 unless terminated earlier by our Board and may be suspended or discontinued at any time.
−Removed: During the fourth quarter of fiscal year 2022 , we repurchased 138,025 shares of common stock under the New Repurchase Program for an aggregate cost of $19.1 million .
−Removed: As of January 1, 2023, $280.9 million remained available for aggregate repurchases of shares under the New Repurchase Program.
+Added: During the fourth quarter of fiscal year 2023 , no shares of common stock were repurchased under the New Repurchase Program.
+Added: During fiscal year 2023 , we repurchased 2,159,985 shares of common stock under the New Repurchase Program for an aggregate cost of $244.6 million .
+Added: As of December 31, 2023, $355.4 million remained available for aggregate repurchases of shares under the New Repurchase Program.
Stock Performance Graph
−Removed: Set forth below is a line graph comparing the cumulative total shareholder return on our common stock against the cumulative total return of the S&P Composite-500 Index, the S&P 500 Life Sciences Tools & Services Industry Index and a Peer Group Index for the five fiscal years from December 31, 2017 to January 1, 2023.
−Removed: Our Peer Group Index consists of Agilent Technologies Inc., Thermo Fisher Scientific Inc., and Waters Corporation.
−Removed: The peer group is the same as the peer group used in the stock performance graph in our Annual Report on Form 10-K for the fiscal year ended January 2, 2022.
+Added: Set forth below is a line graph comparing the cumulative total shareholder return on our common stock against the cumulative total return of the S&P Composite-500 Index and the S&P 500 Life Sciences Tools & Services Industry Index for the five fiscal years from December 30, 2018 to December 31, 2023.
Comparison of Five-Year Cumulative Total Return
−Removed: Among PerkinElmer, Inc.
−Removed: Common Stock, S&P Composite-500,
−Removed: S&P 500 Life Sciences Tools & Services Industry Index and Peer Group Index
+Added: Among Revvity, Inc.
+Added: Common Stock, S&P Composite-500 and
+Added: S&P 500 Life Sciences Tools & Services Industry Index
TOTAL RETURN TO SHAREHOLDERS
(Includes reinvestment of dividends)
−Removed: 31-Dec-17 30-Dec-18 29-Dec-19 3-Jan-21 2-Jan-22 1-Jan-23
−Removed: PerkinElmer, Inc.
12/30/2018 12/29/2019 1/3/2021 1/2/2022 1/1/2023 12/31/2023
+Added: Revvity, Inc.
+Added: $ 100.00 $ 125.96 $ 186.77 $ 262.16 $ 183.17 $ 143.12
S&P 500 Index $ 100.00 $ 131.49 $ 155.68 $ 200.37 $ 164.08 $ 207.21
S&P 500 Life Sciences Tools & Services Industry Index $ 100.00 $ 132.52 $ 176.28 $ 244.55 $ 188.53 $ 182.72
−Removed: Peer Group Index $ 100.00 $ 111.08 $ 157.75 $ 219.67 $ 313.61 $ 266.70
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.